Rosiglitazone-induced granulomatous hepatitis

Journal of Clinical Gastroenterology

Volumn 34, Issue 5, 2002, Pages 582-584

  Dhawan, Manish ^a   Agrawal, Radheshyam ^a   Ravi, Jan ^a   Gulati, Sangeeta ^a   Silverman, Jan ^a   Nathan, Girija ^a   Raab, Stephen ^a   Brodmerkel, George ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

Granulomatous hepatitis; Hepatotoxicity; Rosiglitazone

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CIMETIDINE; GLIPIZIDE; ROSIGLITAZONE; TROGLITAZONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG RESPONSE; GRANULOMATOUS HEPATITIS; HEARTBURN; HUMAN; LIVER CELL DAMAGE; LIVER FUNCTION TEST; LIVER TOXICITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; BIOPSY; GRANULOMA; HEPATITIS, TOXIC; HUMANS; HYPOGLYCEMIC AGENTS; LIVER; MALE; THIAZOLES; THIAZOLIDINEDIONES; TIME FACTORS;

EID: 0036224989     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200205000-00021     Document Type: Article

References (9)

1. Thiazolidinediones
2. Rosiglitazone is not associated with hepatotoxicity
3. Hepatic failure in a patient taking rosiglitazone
4. Hepatocellular injury in a patient receiving rosiglitazone
5. Granulomas of the liver
6. Hepatic manifestations of sarcoidosis and other granulomatous diseases: Study based on histologic examination of tissue obtained by needle biopsy of liver
7. Granulomatous hepatitis: Analysis of 63 cases and review of the literature
8. Hepatic granulomas: Experience over a 10-year period in the west of Scotland
9. Drug-induced granulomatous hepatitis